MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    The Parkinson’s Disease Composite of Executive-Functioning (PaCEF): A measure for detecting cognitive decline for Parkinson’s disease clinical trials

    C. Young, B. Cholerton, M. Shahid, C. Abdelnour, C. Zabetian, T. Montine, K. Poston (Stanford, USA)

    Objective: To develop a cognitive composite measure that is sensitive to decline in executive functioning for use in Parkinson’s disease (PD) clinical trials. Background: The…
  • 2023 International Congress

    Cardio-respiratory fitness is associated with corticospinal excitability and motor learning in Parkinson’s Disease.

    JC. Cristini, M. Beck, L. Rodrigues, B. De-Las-Heras, S. Steib, A. Dagher, J. Doyon, J. Lundbye-Jensen, M. Roig (Montreal, Canada)

    Objective: To explore associations between cardio-respiratory fitness (VO2peak), cortico-spinal excitability (CSE) and motor learning in people with Parkinson's Disease (PwPD). Background: PwPD show alterations in…
  • 2023 International Congress

    Video-Based Motor Function Assessment by Professional Raters or by Software in Patients with Parkinson’s Disease

    WX. Wu, GJ. Jing, XX. Xu, LZZ. Li, YF. Yang, GXD. Guo (Shanghai, China)

    Objective: To evaluate the consistency of objective movement variables between a computer vision-based movement dysfunction assessment software (MoDAS) and professional raters in video-based motor function…
  • 2023 International Congress

    Amplifying or suppressing subthalamic beta oscillations in real-time in Parkinson’s disease using evoked interference deep brain stimulation (eiDBS): feasibility in the human

    D. Escobar, B. Campbell, S. Mesbah, L. Favi Bocca, J. Liao, R. Rammo, S. Nagel, A. Machado, K. Baker (Cleveland, USA)

    Objective: ​​​​​ ​​To assess the feasibility of continuously amplifying or suppressing subthalamic beta oscillations in real-time in Parkinson's disease (PD) patients using a bidirectional, closed-loop brain…
  • 2023 International Congress

    A Parkinson Shoe with Combined Plantar Pressure and Vibratory Stimulation in Parkinson’s Disease Patients with Freezing of Gait: A Randomized Controlled Trial with Plantar Pressure Analysis

    W. Phuenpathom, P. Panyakaew, P. Vateekul, D. Surangsrirat, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of PD shoes on plantar pressure in PD patients with FOG. Background: Dysfunction of peripheral sensory systems, including decreased cutaneous mechanoreceptors…
  • 2023 International Congress

    GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase shows evidence of pharmacological efficacy in an animal model of Parkinson’s disease.

    B. Calvo-Flores Guzman, N. Perez-Carmona, A. Garcia-Collazo, E. Cubero, X. Barril, M. Bellotto, J. Taylor (Lugano, Switzerland)

    Objective: To investigate the effect of the structurally targeted allosteric regulator GT-02287 on rotenone-induced neurotoxic effects in a Parkinson’s disease animal model. Background: Mutations in…
  • 2023 International Congress

    Association Between Antiepileptic Drugs and Subsequent Parkinson’s Disease in East London

    Q. Zhang, J. Bestwick, R. Dobson, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the association between antiepileptic drugs (AEDs) prescription and subsequent Parkinson’s disease (PD). Background: Recent observational studies have highlighted an association between epilepsy…
  • 2023 International Congress

    Diagnostic accuracy of susceptibility map-weighted MRI for discriminating tremor-dominant Parkinson’s disease and essential tremor

    MK. Yoon, S. Jo, S. Lee, J. Lee, CH. Suh, SJ. Chung (Seoul, Republic of Korea)

    Objective: We investigated the diagnostic accuracy of nigrosome using susceptibility map-weighted imaging (SMwI) in distinguishing tremor-dominant Parkinson's disease (PD) and essential tremor (ET). Background: Tremor is…
  • 2023 International Congress

    Correlation of clinical profile of Parkinsonism with molecular imaging

    S. Lavania, A. Pattojoshi, AH. Khan (Agra, India)

    Objective: CORRELATION OF CLINICAL PROFILE OF PARKINSONISM WITH MOLECULAR IMAGING (TRODAT AND PET-CT BRAIN) Background: The current study aims to establish the role of Molecular…
  • 2023 International Congress

    Free-viewing eye tracking in Parkinson’s disease and correlation with clinical features

    A. Gallagher, H. Elliott, J. Inocentes, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)

    Objective: The objective of our study is to determine whether differences in saccade amplitude/velocity in combination with pupillary dynamics and blink rate in a cohort…
  • « Previous Page
  • 1
  • …
  • 352
  • 353
  • 354
  • 355
  • 356
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley